Harvard Update in Clinical Cardiology 2025 (Videos + Slides PDFs)

Description

📍Update in Clinical Cardiology will be held on October 15 – 17, 2025. You have the option to attend either online, as the course is live-streamed, or in person in Boston, MA. All sessions will be recorded and made available to all participants to view online, at your convenience.

 ▶︎ COURSE OVERVIEW

Update in Clinical Cardiology provides comprehensive updates for state-of-the-art care and guidance to incorporate them into daily practice to optimize patient outcomes. Coverage includes:

✅ Coronary Artery Disease

✅ Diabetes and Obesity

✅ Valvular Heart Disease

✅ Heart Failure (reduced and preserved ejection fraction)

✅ Cardiomyopathies

✅ Dyslipidemia

✅ Hypertension

✅ Exercise and Cardiovascular Benefits

✅ Atrial Fibrillation

✅ Supraventricular Tachycardia

✅ Ventricular Arrhythmias

✅ Thoracic Aortic Disease

✅ Pericarditis

✅ Peripheral Arterial Disease

✅ Renal Artery Stenosis

✅ Renal Artery Denervation

✅ Pulmonary Embolism and Venous Thromboembolism

✅ Cardio-Oncology

✅ Adult Congenital Heart Disease

✅ Cardiac Critical Care

✅ Ischemia with Non-Obstructive Coronary Arteries (INOCA)

✅Spontaneous Coronary Artery Dissection (SCAD)

✅ Cardiac Biomarkers

✅ Heart Disease in Pregnancy

✅ Sports Cardiology

✅ Pulmonary Hypertension

✅ Endocarditis

💯 The faculty is assembled from the best clinician-educators at Harvard Medical School and Massachusetts General Hospital and is designed to deliver the highest quality educational experience:

• Teaching practical, effective clinical reasoning and approaches that enable you to practice state-of-the-art clinical cardiology
• Allowing ample time for participants to interact with faculty and to pose and get answers to their specific questions, including Q&A sessions and case-based panel discussions
• Providing the latest information in an engaging manner and clinically usable context so that you have knowledge you can “take home” and immediately apply to patient care

 🗒 2025 PROGRAM HIGHLIGHTS

☛ Management of obesity and diabetes for improved cardiovascular health outcomes

☛ Use of GLP-1 agonists and SGLT2-inhibitors

☛ Acute coronary syndrome guidelines writing committee chair, Dr. Michelle O’Donoghue, presents answers to your questions about the  new guidelines for diagnosis and treatment

☛ New clinical trials: data findings, updates, and implications for daily practice

☛ Novel transcatheter and structural treatment options: important updates for the management of valvular disease

☛ Optimized approaches to heart failure and cardiomyopathies, including hypertrophic cardiomyopathy and cardiac amyloidosis

☛ Advances in electrical devices and mechanical support

☛ Complex coronary artery disease management in the cath lab with novel diagnostic and revascularization techniques

☛ Keynote talk from leading clinical trialist Dr. Marc Sabatine, reviewing the landscape of cardiovascular clinical trials

 🔴 Note:  This course does not include any certificate or CME credits. It is provided solely for educational and self-learning purposes.